Found 4 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Lysophosphatidic acid receptor 1
(Homo sapiens (Human)) | BDBM251731
(US10100018, Example 67 | US9464060, 67)Show SMILES COc1cccc(F)c1Oc1ccc(cc1)C(=O)N(CC1CC1)Cc1ccc(cc1)C(O)=O Show InChI InChI=1S/C26H24FNO5/c1-32-23-4-2-3-22(27)24(23)33-21-13-11-19(12-14-21)25(29)28(15-17-5-6-17)16-18-7-9-20(10-8-18)26(30)31/h2-4,7-14,17H,5-6,15-16H2,1H3,(H,30,31) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... |
US Patent US10100018 (2018)
BindingDB Entry DOI: 10.7270/Q2PR7Z0N |
More data for this Ligand-Target Pair | |
Lysophosphatidic acid receptor 5
(Homo sapiens (Human)) | BDBM251731
(US10100018, Example 67 | US9464060, 67)Show SMILES COc1cccc(F)c1Oc1ccc(cc1)C(=O)N(CC1CC1)Cc1ccc(cc1)C(O)=O Show InChI InChI=1S/C26H24FNO5/c1-32-23-4-2-3-22(27)24(23)33-21-13-11-19(12-14-21)25(29)28(15-17-5-6-17)16-18-7-9-20(10-8-18)26(30)31/h2-4,7-14,17H,5-6,15-16H2,1H3,(H,30,31) | UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... |
US Patent US9464060 (2016)
BindingDB Entry DOI: 10.7270/Q23R0RT0 |
More data for this Ligand-Target Pair | |
Lysophosphatidic acid receptor 1
(Homo sapiens (Human)) | BDBM251731
(US10100018, Example 67 | US9464060, 67)Show SMILES COc1cccc(F)c1Oc1ccc(cc1)C(=O)N(CC1CC1)Cc1ccc(cc1)C(O)=O Show InChI InChI=1S/C26H24FNO5/c1-32-23-4-2-3-22(27)24(23)33-21-13-11-19(12-14-21)25(29)28(15-17-5-6-17)16-18-7-9-20(10-8-18)26(30)31/h2-4,7-14,17H,5-6,15-16H2,1H3,(H,30,31) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... |
US Patent US10100018 (2018)
BindingDB Entry DOI: 10.7270/Q2PR7Z0N |
More data for this Ligand-Target Pair | |
Lysophosphatidic acid receptor 1
(Homo sapiens (Human)) | BDBM251731
(US10100018, Example 67 | US9464060, 67)Show SMILES COc1cccc(F)c1Oc1ccc(cc1)C(=O)N(CC1CC1)Cc1ccc(cc1)C(O)=O Show InChI InChI=1S/C26H24FNO5/c1-32-23-4-2-3-22(27)24(23)33-21-13-11-19(12-14-21)25(29)28(15-17-5-6-17)16-18-7-9-20(10-8-18)26(30)31/h2-4,7-14,17H,5-6,15-16H2,1H3,(H,30,31) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... |
US Patent US9464060 (2016)
BindingDB Entry DOI: 10.7270/Q23R0RT0 |
More data for this Ligand-Target Pair | |